Skip to main content
TipRanks
Go Ultimate75% OFF

Richard Paul Bryce Insider Profile

4 Followers

Richard Paul Bryce, Chief Medical Officer at enGene Holdings, holds ― shares in enGene Holdings (Ticker: ENGN), holds 121.66K shares in Puma Biotechnology (Ticker: PBYI), holds ― shares in Rain Oncology (Ticker: ~RAIN).

Richard Paul Bryce's Trading History

PBYI
Puma Biotechnology
Apr 06, 2021Title of Reporting Person: Chief Medical and ScienInformative Sell4.17K$893.00K
~RAIN
Rain Oncology
――――
ENGN
enGene Holdings
―Chief Medical Officer――

You May Also Like

Richard Paul Bryce insider profile FAQ

What is the percentage of profitable transactions made by Richard Paul Bryce?
The percentage of profitable transactions made by Richard Paul Bryce is 77%.
What is the average return per transaction made by Richard Paul Bryce?
The average return per transaction made by Richard Paul Bryce is 25.40%.
What stocks does Richard Paul Bryce hold?
Richard Paul Bryce holds: ENGN, PBYI, ~RAIN stocks.
What was Richard Paul Bryce's most profitable transaction?
Richard Paul Bryce’s most profitable transaction was an Informative Sell of PBYI stock on February 3, 2021. The return on the trade was 80.80%.
What is Richard Paul Bryce's role in enGene Holdings?
Richard Paul Bryce's role in enGene Holdings is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.